abs335.txt	widespread	resistance	to	antimicrobial	and	cancer	therapeutics	is	evolving	inevery	country	worldwide	has	a	direct	impact	on	global	health		agriculture	andthe	economy	the	specificity	selectivity	of	bioactive	peptide	naturalproducts	present	possible	stopgap	measure	address	ongoing	deficit	newtherapeutic	compounds	pepsavi-ms	(statistically-guided	peptidesprioritized	via	mass	spectrometry)	an	adaptable	method	for	analysis	ofnatural	product	libraries	rapidly	identify	peptides	this	pipelinewas	validated	screening	cyclotide-rich	botanical	species	viola	odorataand	identification	known	anticancer	cyclotidecycloviolacin	o2	herein	we	validate	novel	bioactivities	theanthelmintic	v	odorata	cyclotide	cycloviolacin	o8	(cyo8)	including	micromolaranticancer	activity	against	pc-3	prostate	mda-mb-231	breast	ovcar-3	ovariancancer	cell	lines	antifungal	agricultural	pathogenfusarium	graminearum	reduction/alkylation	strategy	in	tandem	with	pepsavi-msanalysis	also	revealed	several	previously	uncharacterized	putatively	bioactivecyclotides	downstream	implementation	ultraviolet	photodissociation	(uvpd)tandem	spectrometry	demonstrated	cyo8	as	addresstraditionally	difficult-to-sequence	work	emphasizes	thetherapeutic	potential	natural	necessity	developing	robust	analytical	tools	deconvolute	nature'scomplexity
